These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 14962364

  • 1. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium.
    Ginsburg H, Golenser J.
    Redox Rep; 2003; 8(5):276-9. PubMed ID: 14962364
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels.
    Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H.
    Biochem Pharmacol; 2003 Sep 01; 66(5):809-17. PubMed ID: 12948862
    [Abstract] [Full Text] [Related]

  • 3. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
    Safeukui I, Mangou F, Malvy D, Vincendeau P, Mossalayi D, Haumont G, Vatan R, Olliaro P, Millet P.
    Biochem Pharmacol; 2004 Nov 15; 68(10):1903-10. PubMed ID: 15476661
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action.
    Ginsburg H, Famin O, Zhang J, Krugliak M.
    Biochem Pharmacol; 1998 Nov 15; 56(10):1305-13. PubMed ID: 9825729
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.
    Famin O, Krugliak M, Ginsburg H.
    Biochem Pharmacol; 1999 Jul 01; 58(1):59-68. PubMed ID: 10403519
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of glutathione in the detoxification of ferriprotoporphyrin IX in chloroquine resistant Plasmodium berghei.
    Platel DF, Mangou F, Tribouley-Duret J.
    Mol Biochem Parasitol; 1999 Jan 25; 98(2):215-23. PubMed ID: 10080390
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs.
    Zhang J, Krugliak M, Ginsburg H.
    Mol Biochem Parasitol; 1999 Mar 15; 99(1):129-41. PubMed ID: 10215030
    [Abstract] [Full Text] [Related]

  • 11. Mode of action of antimalarial drugs.
    Fitch CD.
    Ciba Found Symp; 1983 Mar 15; 94():222-32. PubMed ID: 6341003
    [Abstract] [Full Text] [Related]

  • 12. Is the expression of genes encoding enzymes of glutathione (GSH) metabolism involved in chloroquine resistance in Plasmodium chabaudi parasites?
    Ferreira ID, Nogueira F, Borges ST, do Rosário VE, Cravo P.
    Mol Biochem Parasitol; 2004 Jul 15; 136(1):43-50. PubMed ID: 15138066
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S, Walter RD, Müller S.
    Biochem J; 2002 Dec 15; 368(Pt 3):761-8. PubMed ID: 12225291
    [Abstract] [Full Text] [Related]

  • 16. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O, Ginsburg H.
    Parasite; 2003 Mar 15; 10(1):39-50. PubMed ID: 12669348
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
    Friebolin W, Jannack B, Wenzel N, Furrer J, Oeser T, Sanchez CP, Lanzer M, Yardley V, Becker K, Davioud-Charvet E.
    J Med Chem; 2008 Mar 13; 51(5):1260-77. PubMed ID: 18260613
    [Abstract] [Full Text] [Related]

  • 20. Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine.
    Warhurst DC.
    Malar J; 2003 Sep 19; 2():31. PubMed ID: 14599295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.